Table 12. Comparison of TMZ effects on hearts subjected to AHF–obese males vs. obese females (luteal) (n = 6).
| Control | ||||||
| Parameters | Males | Females | Sig. | |||
| Heart rate (%) |
31.75 ± 2.85 | 38.49 ± 10.56 | ns | |||
| LVDevP (%) |
2411.10 ± 458.16 | 1725.24 ± 397.04 | ns | |||
| LVEDP (%) |
142.48 ± 10.43 | 574.86 ± 308.07 | ns | |||
| LVESP (%) |
147.98 ± 11.77 | 521.49 ± 240.36 | * | |||
| TMZ at CAHF | TMZ at RAHF | |||||
| Males | Females | Sig. | Males | Females | Sig. | |
| Heart rate (%) |
30.17 ± 2.62 | 36.99 ± 3.84 | ns | 31.78 ± 2.38 | 32.55 ± 2.48 | ns |
| LVDevP (%) |
1678.49 ± 470.27 | 3199.25 ± 743.72 | ns | 4522.35 ± 742.07 | 5400.37 ± 887.21 | ns |
| LVEDP (%) |
158.98 ± 15.10 | 140.93 ± 11.62 | ns | 141.43 ± 9.98 | 126.83 ± 7.53 | ns |
| LVESP (%) |
164.74 ± 16.48 | 145.23 ± 12.91 | ns | 147.96 ± 12.18 | 132.12 ± 9.01 | ns |
Data represent the last ten minutes of the RAHF phase and expressed as a percentage of CAHF. Significance is expressed as *p<0.05 vs. obese males. RPP: rate pressure product; (dp/dt)max: index of myocardial contraction velocity; LVDevP: left ventricular developed pressure; LVEDP: left ventricular end diastolic pressure; LVESP: left ventricular end systolic pressure; CAHF: critical acute heart failure; RAHF: recovery acute heart failure; Sig.: significance; ns: not significant.